DefenCath® (taurolidine and heparin) catheter lock solution is indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis (HD) through a central venous catheter (CVC). This drug is indicated for use in a limited and specific population of patients.

Learn more

In the News

Taurolidine cited as an emerging technology in the treatment of Catheter Related Bloodstream Infections

Read more at Becker’s Hospital Review: Infection Control & Clinical Quality

LOCK-IT-100 Trial named in column on the risk of bloodstream infections for long term care patients undergoing dialysis.

Read more at McKnight’s Long Term Care